BioNTech SE Proceeds From Borrowings Classified As Financing Activities
BioNTech SE (BNTX) reported Proceeds From Borrowings Classified As Financing Activities of EUR 6.70 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities · last filed 2026-03-10
| Period end | Proceeds From Borrowings Classified As Financing Activities 12 month | Proceeds From Borrowings Classified As Financing Activities 12 month as first filed |
|---|---|---|
| 2025-12-31 | 6.70M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 300.00K EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 800.00K EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 0.00 EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 156.00M EUR 20-F · filed 2023-03-27 | 156.03M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 11.00M EUR 20-F/A · filed 2022-10-26 | |
| 2018-12-31 | 5.60M EUR 20-F · filed 2021-03-30 |